First drug that slows down Alzheimer’s disease already exists, but why doctors are skeptical?

Nine months after its introduction in the U.S., Eisai and Biogen’s Alzheimer’s drug Leqembi is encountering significant resistance

from Technology Org https://ift.tt/41FZWQm
via IFTTT